Publicaciones (136) Publicaciones de JORGE FRANCISCO GOMEZ CEREZO

2024

  1. Cyclosporine A in hospitalized COVID-19 pneumonia patients to prevent the development of interstitial lung disease: a pilot randomized clinical trial

    Scientific Reports, Vol. 14, Núm. 1

  2. Post-event follow-up costs in patients with atherosclerotic cardiovascular disease in Spain

    Frontiers in Cardiovascular Medicine, Vol. 11

  3. Practical consensus for the treatment and follow-up of primary aldosteronism: a multidisciplinary consensus document

    Endocrine

  4. Screening and diagnosis of primary aldosteronism. Consensus document of all the Spanish Societies involved in the management of primary aldosteronism

    Endocrine

2023

  1. Evolocumab como tratamiento de la dislipemia secundaria a lorlatinib

    Clínica e investigación en arteriosclerosis, Vol. 35, Núm. 2, pp. 88-90

  2. Results of the screening program for Fabry disease in patients with cornea verticillata at the University Hospital of Navarre

    Revista Clinica Espanola, Vol. 223, Núm. 1, pp. 25-31

2022

  1. A practical approach to semaglutide use in patients with type-2 diabetes

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SD, pp. 1-9

  2. Actualización sobre las nuevas formas de consumo de tabaco

    Clínica e investigación en arteriosclerosis, Vol. 34, Núm. 6, pp. 330-338

  3. Miocarditis aguda en varón joven tras la primera dosis de la vacunación frente al SARS-CoV-2

    Revista Española de Casos Clínicos en Medicina Interna (RECCMI), Vol. 7, Núm. 3, pp. 41-44

  4. Statin-associated muscle symptoms: Myth or reality?

    Revista Clinica Espanola, Vol. 222, Núm. 10, pp. 602-611

  5. Treatment patterns and use of healthcare resources of patients with atherosclerotic cardiovascular disease and hypercholesterolemia and patients with familial hypercholesterolemia in Spain: Protocol of the Reality study

    Frontiers in Cardiovascular Medicine, Vol. 9

  6. Update on new forms of tobacco use

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 6, pp. 330-338

2021

  1. Acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolism: A randomised clinical trial

    Journal of Clinical Medicine, Vol. 10, Núm. 13

  2. Clinical Characteristics, Frailty, and Mortality of Residents With COVID-19 in Nursing Homes of a Region of Madrid

    Journal of the American Medical Directors Association, Vol. 22, Núm. 2, pp. 245-252.e2

  3. Clinical characterization and outcomes of 85 patients with neurosarcoidosis

    Scientific Reports, Vol. 11, Núm. 1

  4. Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients

    Joint Bone Spine, Vol. 88, Núm. 6

  5. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation

    BMC Cardiovascular Disorders, Vol. 21, Núm. 1

  6. Effect of intravenous iron on functional outcomes in hip fracture: A randomised controlled trial

    Age and Ageing, Vol. 50, Núm. 1, pp. 127-134

  7. Effectiveness of glucocorticoids in patients hospitalized for severe SARS-CoV-2 pneumonia

    Medicina Clinica, Vol. 156, Núm. 5, pp. 221-228

  8. International public awareness of peripheral artery disease

    Vasa - European Journal of Vascular Medicine, Vol. 50, Núm. 4, pp. 294-300